About Cryopreservation Media
Cryopreservation Media is designed to maintain and preserve cells at low environmental temperature and decreases the risk of infection by microbes and other cell types. It provides a safe environment for cells and tissues while undergoing freezing, storage and thawing process. This is specially framed media which contains a defined serum substitute as well as an improved concentration of a cryopreservative that increases the recovery and viability of healthy cells compared to conventional freezing media.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Cryopreservation Media is a fragmented market due to the presence of several regional and international players. The players are focusing on planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Cryopreservation Media market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Thermo Fisher Scientific, Inc. (United States), Osiris Therapeutics, Inc (United States), Sigma-Aldrich Corporation (United States), VWR Corporation (United States), Biolife Solutions, Inc. (United States), Lifeline Scientific, Inc. (United States), Cesca Therapeutics, Inc. (United States), BioCision, LLC (United States), Core Dynamics, Ltd. (Israel), Custom Biogenic Systems, Inc. (United States), So-Low Environmental Equipment Co., Inc. (United States) and Princeton Cryotech, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are So-Low Environmental Equipment Co., Inc. (United States) and Princeton Cryotech, Inc. (United States).
Segmentation Overview
AMA Research has segmented the market of Global Cryopreservation Media market by Type (Lysogenic broth, Protein-free media, Specialty media, Serum-free media and Chemically-defined media), Application (Biobanks, Gene Banks, Hospitals, Tissue engineering, Stem cell technologies, Therapeutic Applications, Cancer and Research Applications, Clinical Trials and Others) and Region.
On the basis of geography, the market of Cryopreservation Media has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Bio-specimens Types, the sub-segment i.e. Human Tissue Samples will boost the Cryopreservation Media market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Adoption in Conserving Cord Blood Stem Cells of Newborns and The increasing Trend of Cryopreservation of Eggs and Embryos
Market Growth Drivers:
Increasing Healthcare Expenditure, Increasing R&D Investments, Advancement in Biobanking and Advances in Regenerative Medicine
Challenges:
Lack of Consumer Awareness Regarding Cryopreservation Media
Restraints:
High Cost of Advanced Techniques and Stability Issues, Tissue Injury During Freezing & Thawing
Opportunities:
Increasing Awareness for Cryopreservation Media in Emerging Countries
Market Leaders and their expansionary development strategies
In August 2023, Thermo Fischer Scientific completed acquisition of CorEvitas. a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity (“Audax”), for USD 912.5 million in cash.
In August 2023, Thermo Fischer Scientific recognized by R&D 100 Awards for innovation in science and technology, honoring the top 100 revolutionary products in science and technology from around the world, for three unique innovations that aid researchers’ and scientists’ work in a variety of life science applications, including bioproduction and small-molecule analysis.
Key Target Audience
Cryopreservation centers, Health care centers, Hospitals, Pharmaceutical labs, Cancer and Research centers and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.